India strengthening clinical trial regulatory capacity, gov says

By Nick Taylor

- Last updated on GMT

India strengthening clinical trial regulatory capacity, gov says

Related tags: Clinical trial, Contract research organization

The Indian regulator is adding staff and strengthening infrastructure to enforce its new clinical trial guidelines, a government minister said.

In recent years India has tried to tighten clinical trial regulations to counter claims poor practices are a threat to patient health. The next step is equipping the regulator to enforce the new guidelines.

Shri Ghulam Nabi Azad, the Indian minister of health and family, said: “The manpower and infrastructure of CDSCO (Central Drugs Standard Control Organization) is being strengthened for strict compliance of the provisions of the said rules​.”

Azad made the statement in response to questioning in parliament about oversight of clinical trials in India. The questioners wanted to know what clinical trial violations regulators have found and what actions they took in response.

In the past three years 1,743 patients died in trials in India, although few of these were as a direct result of research. Over the same period 2,169 trials were registered. A document shared by Azad shows six investigations, including one from 2008, into alleged violations of clinical trial regulations.

The investigations looked into practices at sponsors and CROs (contract research organisations), both local and global, as well as two doctors and a non-governmental organisation (NGO). Warning letters, temporary clinical trial bans, and suspensions of research licenses were some of the case outcomes.

India has also started making sponsors and CROs pay compensation to the families of some patients who died during clinical trials. The families of 22 patients who died in 2010 have received payments.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Related suppliers

Follow us


View more